Cargando…

Moyamoya Syndrome Presenting as Refractory Status Epilepticus in a 32-Year-Old Female

Moyamoya disease (MMD) is a rare cerebrovascular occlusion condition characterized by ‎progressive stenosis in the terminal portion of the internal carotid arteries on both sides. The measured incidence of MMD is 0.086 per 100,000 people. MMD has variable ‎neurological manifestations, however, seizu...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhashem, Ali T, AlSalem, Khalid H, Sabihah, Sarah J, Alfaraj, Dunya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010915/
https://www.ncbi.nlm.nih.gov/pubmed/33816023
http://dx.doi.org/10.7759/cureus.13624
_version_ 1783673153803780096
author Alhashem, Ali T
AlSalem, Khalid H
Sabihah, Sarah J
Alfaraj, Dunya
author_facet Alhashem, Ali T
AlSalem, Khalid H
Sabihah, Sarah J
Alfaraj, Dunya
author_sort Alhashem, Ali T
collection PubMed
description Moyamoya disease (MMD) is a rare cerebrovascular occlusion condition characterized by ‎progressive stenosis in the terminal portion of the internal carotid arteries on both sides. The measured incidence of MMD is 0.086 per 100,000 people. MMD has variable ‎neurological manifestations, however, seizure is a significant manifestation of MMD with ‎few reported studies. The combination of sickle cell disease (SCD) and MMD confers a much ‎higher risk of ischemic stroke. In this paper, we describe a 32-year-old female with a known ‎case of SCD taking tramadol for a vaso-occlusive crisis, who was presented to the emergency ‎department by a family member due to a low level of consciousness. Despite ongoing ‎management, the patient developed multiple seizure attacks and intubation was ‎performed. A computed tomography (CT) brain angiogram was performed, and the ‎diagnosis of MMD was made. The patient was shifted to the intensive care unit (ICU) and in spite of the ongoing management in the ICU, the patient died. In this case, we highlight the importance of considering MMD as a ‎differential diagnosis when dealing with an SCD patient who developed refractory status epilepticus.‎
format Online
Article
Text
id pubmed-8010915
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-80109152021-04-02 Moyamoya Syndrome Presenting as Refractory Status Epilepticus in a 32-Year-Old Female Alhashem, Ali T AlSalem, Khalid H Sabihah, Sarah J Alfaraj, Dunya Cureus Emergency Medicine Moyamoya disease (MMD) is a rare cerebrovascular occlusion condition characterized by ‎progressive stenosis in the terminal portion of the internal carotid arteries on both sides. The measured incidence of MMD is 0.086 per 100,000 people. MMD has variable ‎neurological manifestations, however, seizure is a significant manifestation of MMD with ‎few reported studies. The combination of sickle cell disease (SCD) and MMD confers a much ‎higher risk of ischemic stroke. In this paper, we describe a 32-year-old female with a known ‎case of SCD taking tramadol for a vaso-occlusive crisis, who was presented to the emergency ‎department by a family member due to a low level of consciousness. Despite ongoing ‎management, the patient developed multiple seizure attacks and intubation was ‎performed. A computed tomography (CT) brain angiogram was performed, and the ‎diagnosis of MMD was made. The patient was shifted to the intensive care unit (ICU) and in spite of the ongoing management in the ICU, the patient died. In this case, we highlight the importance of considering MMD as a ‎differential diagnosis when dealing with an SCD patient who developed refractory status epilepticus.‎ Cureus 2021-03-01 /pmc/articles/PMC8010915/ /pubmed/33816023 http://dx.doi.org/10.7759/cureus.13624 Text en Copyright © 2021, Alhashem et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Emergency Medicine
Alhashem, Ali T
AlSalem, Khalid H
Sabihah, Sarah J
Alfaraj, Dunya
Moyamoya Syndrome Presenting as Refractory Status Epilepticus in a 32-Year-Old Female
title Moyamoya Syndrome Presenting as Refractory Status Epilepticus in a 32-Year-Old Female
title_full Moyamoya Syndrome Presenting as Refractory Status Epilepticus in a 32-Year-Old Female
title_fullStr Moyamoya Syndrome Presenting as Refractory Status Epilepticus in a 32-Year-Old Female
title_full_unstemmed Moyamoya Syndrome Presenting as Refractory Status Epilepticus in a 32-Year-Old Female
title_short Moyamoya Syndrome Presenting as Refractory Status Epilepticus in a 32-Year-Old Female
title_sort moyamoya syndrome presenting as refractory status epilepticus in a 32-year-old female
topic Emergency Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010915/
https://www.ncbi.nlm.nih.gov/pubmed/33816023
http://dx.doi.org/10.7759/cureus.13624
work_keys_str_mv AT alhashemalit moyamoyasyndromepresentingasrefractorystatusepilepticusina32yearoldfemale
AT alsalemkhalidh moyamoyasyndromepresentingasrefractorystatusepilepticusina32yearoldfemale
AT sabihahsarahj moyamoyasyndromepresentingasrefractorystatusepilepticusina32yearoldfemale
AT alfarajdunya moyamoyasyndromepresentingasrefractorystatusepilepticusina32yearoldfemale